Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Xiuhua Wen"'
Autor:
Hongwei Guo, Taiyang Liu, Jie Li, Enzhong Li, Xiuhua Wen, Fujia Chen, Siqaing Li, Yun Li, Qingqiang Yin, Qun Zhu
Publikováno v:
Ecotoxicology and Environmental Safety, Vol 281, Iss , Pp 116619- (2024)
This study investigated the effects of compound probiotics (CP) on AFB1-induced cytotoxicity in Sertoli TM4 cells. The L9 (3 × 3) orthogonal test was conducted to determine the optimal CP required for high AFB1 degradation in the artificial gastroin
Externí odkaz:
https://doaj.org/article/d08df373d7644d6d940917d859db6c84
Publikováno v:
Cellular Physiology and Biochemistry, Vol 37, Iss 5, Pp 1686-1692 (2015)
Background/Aims: Vitamin D status in relation to bladder carcinoma risk was still inconsistent. This study was carried out to evaluate the relationship between vitamin D status and bladder carcinoma risk through a meta-analysis approach. Methods: Pub
Externí odkaz:
https://doaj.org/article/0a87ef87088e44af8df81e6729057d08
Publikováno v:
2022 IEEE International Conference on Trust, Security and Privacy in Computing and Communications (TrustCom).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0d6f3d990a89a0f7902e7b6d34ceb66
https://doi.org/10.1109/trustcom56396.2022.00036
https://doi.org/10.1109/trustcom56396.2022.00036
Publikováno v:
2022 International Conference on Networking and Network Applications (NaNA).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8b1d93c1db5103f80f992f4a3dc12b7
https://doi.org/10.1109/nana56854.2022.00020
https://doi.org/10.1109/nana56854.2022.00020
Publikováno v:
2022 International Conference on Networking and Network Applications (NaNA).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdffeea4d4ebd59fc025bcc1d9cfe832
https://doi.org/10.1109/nana56854.2022.00010
https://doi.org/10.1109/nana56854.2022.00010
Publikováno v:
2021 IEEE 23rd Int Conf on High Performance Computing & Communications; 7th Int Conf on Data Science & Systems; 19th Int Conf on Smart City; 7th Int Conf on Dependability in Sensor, Cloud & Big Data Systems & Application (HPCC/DSS/SmartCity/DependSys).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b5d2fee72e3ea4f2d38244a8f7704df
https://doi.org/10.1109/hpcc-dss-smartcity-dependsys53884.2021.00068
https://doi.org/10.1109/hpcc-dss-smartcity-dependsys53884.2021.00068
Publikováno v:
Oncology Letters
Sorafenib was examined to determine whether it improves postoperative effects during early stage renal cell carcinoma (RCC). A total of 133 patients with early renal clear cell carcinoma (T1-2N0M0) with surgical indications were continuously selected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17da65390052829f6d9e5eebf67b872c
https://doi.org/10.3892/ol.2016.5243
https://doi.org/10.3892/ol.2016.5243
Autor:
Shen Lin, Dong Lin, Yiyuan Li, Lixian Zhong, Wei Zhou, Yajing Wu, Chen Xie, Shaohong Luo, Xiaoting Huang, Xiongwei Xu, Xiuhua Weng
Publikováno v:
Epidemiology and Health, Vol 45 (2023)
OBJECTIVES The aim of this study was to evaluate the disease burden of prostate cancer (PC) and assess key influencing factors associated with the disease expenditures of PC in the United States. METHODS The total deaths, incidence, prevalence, and d
Externí odkaz:
https://doaj.org/article/5786a08f00664389bc9e699b1cee3db8
Autor:
Chen Xie, Xiaoting Huang, Xiuhua Weng, Shen Lin, Shaohong Luo, Xiaojia Huang, Liangliang Dong, Dong Lin, Yaping Huang, Dongni Nian, Xiongwei Xu
Publikováno v:
BMJ Open, Vol 13, Iss 3 (2023)
Objective Rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone, once every 3 weeks (R-CHOP21) is commonly used in non-Hodgkin’s lymphoma (NHL), but accompanied by Pneumocystis carinii pneumonia (PCP) as a fatal treatment complic
Externí odkaz:
https://doaj.org/article/a86ad328c90346d7af47b3fb450eb927
Autor:
Shen Lin, Yaping Huang, Liangliang Dong, Meiyue Li, Yahong Wang, Dian Gu, Wei Wu, Dongni Nian, Shaohong Luo, Xiaoting Huang, Xiongwei Xu, Xiuhua Weng
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Life expectancy for patients with malignant tumors has been significantly improved since the presence of the programmed cell death protein-1/programmed cell death protein ligand-1 (PD-1/PD-L1) inhibitors in 2014, but they impose heavy fin
Externí odkaz:
https://doaj.org/article/35fb62de7a9c44488e05082054416077